Lamictal 5mg chewable/dispersible Tablets Malta - English - Medicines Authority

lamictal 5mg chewable/dispersible tablets

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - lamotrigine - chewable/dispersible tablet - lamotrigine 5 mg - antiepileptics

Lamictal 25 mg chewable/dispersible tablets Malta - English - Medicines Authority

lamictal 25 mg chewable/dispersible tablets

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - lamotrigine - chewable/dispersible tablet - lamotrigine 25 mg - antiepileptics

Lamictal New Zealand - English - Medsafe (Medicines Safety Authority)

lamictal

glaxosmithkline nz limited - lamotrigine 25mg - chewable/dispersible tablet - 25 mg - active: lamotrigine 25mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

Lamictal New Zealand - English - Medsafe (Medicines Safety Authority)

lamictal

glaxosmithkline nz limited - lamotrigine 5mg - chewable/dispersible tablet - 5 mg - active: lamotrigine 5mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

LAMICTAL DISPERSIBLECHEWABLE TABLETS 5 MG Israel - English - Ministry of Health

lamictal dispersiblechewable tablets 5 mg

glaxo smith kline (israel) ltd - lamotrigine - dispersible chewable tablets - lamotrigine 5 mg - lamotrigine - lamotrigine - epilepsy• adults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome.• children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.

LAMICTAL DISPERSIBLECHEWABLE TABLETS 25 MG Israel - English - Ministry of Health

lamictal dispersiblechewable tablets 25 mg

glaxo smith kline (israel) ltd - lamotrigine - dispersible/chewable tablets - lamotrigine 25 mg - lamotrigine - lamotrigine - epilepsy• adults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome.• children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.bipolar disorder• adults aged 18 years and above- prevention of depressive episodes in patients with bipolar i disorder who experience predominantly depressive episodes (see section 5.1).lamictal is not indicated for the acute treatment of manic or depressive episodes.

Lamictal 5 mg chewable/dispersible tablets Ireland - English - HPRA (Health Products Regulatory Authority)

lamictal 5 mg chewable/dispersible tablets

glaxosmithkline (ireland) limited - lamotrigine - chewable/dispersible tablet - 5 milligram(s) - other antiepileptics; lamotrigine

Lamictal 5 mg chewable/dispersible tablets Ireland - English - HPRA (Health Products Regulatory Authority)

lamictal 5 mg chewable/dispersible tablets

pco manufacturing ltd. - lamotrigine - chewable/dispersible tablet - 5 milligram(s) - lamotrigine

Lamictal 25 mg chewable/dispersible tablets Ireland - English - HPRA (Health Products Regulatory Authority)

lamictal 25 mg chewable/dispersible tablets

pco manufacturing ltd. - lamotrigine - chewable/dispersible tablet - 25 milligram(s) - lamotrigine

Lamictal 25 mg chewable/dispersible tablets Ireland - English - HPRA (Health Products Regulatory Authority)

lamictal 25 mg chewable/dispersible tablets

glaxosmithkline (ireland) limited - lamotrigine - chewable/dispersible tablet - 25 milligram(s) - other antiepileptics; lamotrigine